NCT01689662View on ClinicalTrials.gov

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

July 31, 2003

Conditions
Metastatic Renal Cell Carcinoma
Interventions
DRUG

Tc 99m EC20

Trial Locations (1)

77030

Baylor College of Medicine, Houston

Sponsors

Lead Sponsor

Endocyte
All Listed Sponsors
lead

Endocyte

INDUSTRY

NCT01689662 - Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma | Biotech Hunter | Biotech Hunter